Clin2
NCT06745206Worth exploringNot yet recruiting

Heart support medicine during septic shock recovery

Sepsis-induced Cardiomyopathythe Recovery Phase of Septic Shock

Part of Heart & circulation, Infections clinical trials.

This trial tests a medicine that helps your heart pump better during the recovery phase of septic shock. It may improve your heart function and help you get better faster.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must be in the recovery phase of septic shock, meaning your blood pressure is stabilizing and you need less medication to support it.
  • You must have signs that your heart is not pumping as well as it should, based on blood tests or an ultrasound.
  • You must have a catheter in a large vein to monitor your heart and fluid levels.
  • You must not have advanced kidney disease, an irregular heartbeat, or a recent heart attack.
  • You must not be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06118775Not yet recruiting
Testing a heart health tool for septic shock recovery

This trial looks at how well the heart and blood vessels are working in people with septic shock. It helps doctors decide the best way to reduce blood pressure medication safely.

Bogotá
NCT06793020Recruiting
Study of sepsis-related heart damage using a math model

This trial tests a new mathematical model to better diagnose and treat heart problems caused by sepsis. It includes adults with sepsis or septic shock who need strong blood pressure support.

Vilnius
NCT05336357Recruiting
Non-invasive treatment plan for septic shock

This study tests a non-invasive, goal-based treatment approach for people with septic shock—an emergency condition caused by severe infection. It may help by using blood-pressure and circulation targets to guide care without more invasive procedures.

São Paulo
NCT05586282Recruiting
Study proteins that may worsen fluid leaks in shock

This trial studies specific body proteins to understand why fluid can leak from blood vessels during dangerous shock after infection or heart problems. If you (or your representative) qualify, your team will collect information and possibly samples to see whether these proteins relate to recovery and treatment response.

Paris
NCT06366854Not yet recruiting
A new treatment approach for septic shock

This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.

NCT06853574Not yet recruiting
Heart and blood vessel function in sepsis

This study looks at how well the heart and blood vessels work together in people with sepsis or septic shock. It may help doctors understand heart function better during serious infections, which could lead to improved care.

Celje

Hear when a new Sepsis Induced Cardiomyopathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.